Aim-To detect the prevalence of herpes virus-like DNA sequences in AIDS associated Kaposi sarcoma (KSHV) lesions and normal tissue. Methods-KSHV detection was performed by polymerase chain reaction (PCR) using four different sets of primers. PCR products were cloned, sequenced, and analysed. Results-All of four biopsies of Kaposi sarcoma lesions and all of three paraffin embedded Kaposi sarcoma tissues were positive for KSHV, while normal tissue from the same patients was negative. Sequence analysis of amplification products revealed polymorphisms that result in amino acid changes ofthe predicted sequence. Conclusions-KSHV is prevalent in tissues from Kaposi sarcoma, suggesting a role in the development of the tumour. On this basis, anti-herpes virus agents should be considered to control KIAposi sarcoma. (J Clin Pathol 1996;49:306-308) 
Kaposi sarcoma was first recognised in middle aged European men of Mediterranean origin (classical Kaposi sarcoma), but it had also been reported in African men (African or endemic Kaposi sarcoma), in transplant associated immunosupressed individuals, and in individuals infected with HIV.' The histology is similar in all cases, with multifocal, polyclonal tumours that show heterogeneity in cell composition but are dominated by spindle shaped endothelial cells. 2 Kaposi sarcoma is a disease of unknown aetiology and presents in an aggressive form when associated with the acquired immunodeficiency syndrome (AIDS). The Cloning of the PCR products into the pCRII plasmid vector was done using a TA cloning kit (Invitrogen) following the manufacturer's instructions. Sequences were obtained using the chain terminator method on an ABI automatic sequencer. Sequence comparison was done using the Wisconsin GCG software package.9
Results
To determine the incidence of KSHV, genomic DNA was prepared from four individual punch biopsies obtained with informed consent from ks3-5 632 centrated at the sites of the lesions and not disseminated throughout the skin.
Sequence analysis of the 233 bp amplification product suggested the presence of sequence variations between the different samples (see below). These differences could affect the efficient amplification of KSHV sequences found in Kaposi sarcoma samples. Therefore, two different sets of primers were designed which would amplify the 5' 421 bp and the 3' 419 bp of the BDLF1/ORF26-homologous gene. Also, the outermost 5' and 3' primers were used to amplify the entire coding sequence. As indicated in fig 4 , these three combinations of primers efficiently amplify the KSHV sequences, resulting in amplification products with the appropriate sizes. These results confirm the presence of the entire gene in the samples and show the efficiency of each of these combinations of primers in amplifying KSHV sequences in Kaposi sarcoma samples.
As indicated above, preliminary sequencing of the 233 bp amplification product from the BDLFI/0RF26-homologous gene suggested 1 2 3 4 5 6 7 8 c.ii 7IX. These results suggest the possibility of herpes virus strain differences that might be present in different groups of Kaposi sarcoma patients.
Discussion
In this study, KSHV sequences were found in all the Kaposi sarcoma lesions examined. The presence of KSHV was not observed in nonKaposi sarcoma or control tissues. Under the experimental conditions used, less than 0 7 fg of plasmid DNA containing the entire ORF mixed with 100 ng of genomic DNA could be detected. In specific situations were sensitivity might need to be increased, a nested PCR procedure using the external set of primers described here in combination with the original set of primers described by Chang et at3 ( sification includes viruses capable of establishing latent infections and also capable of inducing cell transformation, two properties that describe the putative new virus. Viruses in the Gammaherpesvirinae subfamily are typically 150 kilobases of size. The KSHV sequences published to date comprise only a small portion of this novel herpes virus. Because PCR has been employed to generate all the available fragments of KSHV, the apparent polymorphisms described should be confirmed by direct sequencing of viral DNA fragments. However, if confirmed, the sequence differences found might help in the classification of this virus and help identify individual strains of KSHV. Future efforts to clone more viral sequences should also assist in the proper classification of this virus. The presence of putative polymorphism in KSHV raises the possibility of strain differences which might have different properties. Because different types of neoplasm have been associated with KSHV it will be important to determine any possible correlation between the different sequences and disease.
It has been suggested that transcripts corresponding to the putative new virus are found in Kaposi sarcoma samples.4 However, no data were presented by the authors and no information was provided about which genes are expressed. Although some viral gene expression would be expected, with the limited sequence information available it might be difficult to identify viral transcripts. The lack of observable virus particles in Kaposi sarcoma samples suggest that the virus is present in a latent state. Therefore, efforts towards inducing virus expression might prove helpful in its isolation. Based on the accumulating evidence suggesting the role of a herpes virus in the development of Kaposi sarcoma, anti-herpes virus agents should be considered to control the tumour.
